Most Recent
Pfizer loses patent case over Enbrel generic
Pfizer has lost a patent infringement lawsuit against Samsung Bioepis over the generic version of its blockbuster autoimmune drug Enbrel, with a judge finding all but one of the patent's claims is invalid. 
Arrotex can’t back up iron supplement claims, lawsuit alleges
The maker of Maltofer iron supplements is suing Arrotex over ads that claim its Ferro-grad C iron supplement is faster acting and reduces the risk of constipation. 
Breast implants class action takes aim again at Allergan’s ‘state of the art’ defence
A class action against Allergan over recalled breast implants is trying again to strike out the US drug company’s defence that there was no known causal link between its implants and a type of cancer at the time of supply.
Judge suggests hearing GCO bid in J&J class action after defence
A judge has suggested there may be merit in waiting for Johnson & Johnson to file a defence before deciding an application for a group costs order in a class action accusing the company of selling defective, carcinogenic talcum powder.
Ex-Eagles player’s AFL concussion case struck out
Former West Coast Eagles player Daniel Venables' case against two doctors and a neurologist has been struck out, with a judge finding he had failed to adequately plead a negligence case.
Breast implants class action loses bid to strike out Allergan defence
A class action against Allergan over recalled breast implants has lost its bid to strike out the US drug company’s defence that there was no known causal link between its implants and a certain form of cancer at the time of supply.
Norton Rose hires corporate partner from Baker McKenzie
Norton Rose Fulbright has hired the former co-head of Baker McKenzie's Australian healthcare and life sciences group to join its corporate practice group in Sydney.
Court orders soft class closure in J&J cold medicine class action
A judge has granted Johnson & Johnson's bid for soft class closure in a class action over alleged ineffective cold medications, saying it would aid in settlement negotiations. 
Construction PRO
Perth Day Hospital loses nuisance claim against neighbouring gym
A judge has tossed a nuisance claim by the Perth Day Hospital against its neighbour Fitness Cartel, finding its use of the property for "hypersensitive" surgery and medical procedures was not an 'ordinary use' protected by nuisance law.
‘Nearly every other matter is more important’: Judge in Merck TM battle fed up
"Quite unsatisfactory", is how a judge has described a revived intellectual property dispute between German drug maker Merck KGaA and US drug company Merck Sharp & Dohme over the alleged use of the ‘Merck’ mark in Australia.